www.fdanews.com/articles/138156-mingsight-relin-form-joint-venture-to-develop-diabetic-eye-disease-drug-in-china
MingSight, Relin Form Joint Venture to Develop Diabetic Eye Disease Drug in China
July 6, 2011
Shenzhen Relin Medicine and MingSight Pharmaceuticals have formed a joint venture, Jiangsu MingSight-Relin Pharmaceutical, to develop and commercialize MS-553 as an oral therapy for diabetic eye disease in China.
PBR
PBR